Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1
Unknown1
Not Yet Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07106411Not Yet RecruitingPrimary

CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study

NCT07078136RecruitingPrimary

Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis

NCT05101772UnknownPrimary

25G and 22G Puncture Needles

Showing all 3 trials

Research Network

Activity Timeline